ARTICLE | Company News
Avid Therapeutics deal
November 14, 1994 8:00 AM UTC
Avid (Philadelphia) received exclusive rights from Emory University to develop polyoxometalates to treat respiratory syncytial virus (RSV) and influenza. Avid said that although the compounds have a h...